Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radboud J Duintjer Tebbens

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
BMC Infectious Diseases|April 19, 2015
Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccinationDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Journal of Vaccines & Vaccination|July 11, 2017
Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global CessationRadboud J Duintjer Tebbens, Lee M Hampton, Steven G F Wassilak, et al.
The Journal of Infectious Diseases|October 16, 2014
Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccinationKasper H Kisjes, Radboud J Duintjer Tebbens, Gregory S Wallace, et al.
Plos Neglected Tropical Diseases|October 12, 2012
Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in ZanzibarChristian Schaetti, Mitchell G Weiss, Said M Ali, et al.
The Journal of Infectious Diseases|December 16, 2014
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013Dominika A Kalkowska, Radboud J Duintjer Tebbens, Itamar Grotto, et al.
Vaccine|October 30, 2010
Economic analysis of the global polio eradication initiativeRadboud J Duintjer Tebbens, Mark A Pallansch, Stephen L Cochi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradicationRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 17, 2008
Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk managementRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 10, 2018
Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated SubpopulationsRadboud J Duintjer Tebbens, Mark A Pallansch, Stephen L Cochi, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|April 19, 2015
Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccinationDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Journal of Vaccines & Vaccination|July 11, 2017
Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global CessationRadboud J Duintjer Tebbens, Lee M Hampton, Steven G F Wassilak, et al.
The Journal of Infectious Diseases|October 16, 2014
Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccinationKasper H Kisjes, Radboud J Duintjer Tebbens, Gregory S Wallace, et al.
Plos Neglected Tropical Diseases|October 12, 2012
Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in ZanzibarChristian Schaetti, Mitchell G Weiss, Said M Ali, et al.
The Journal of Infectious Diseases|December 16, 2014
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013Dominika A Kalkowska, Radboud J Duintjer Tebbens, Itamar Grotto, et al.
Vaccine|October 30, 2010
Economic analysis of the global polio eradication initiativeRadboud J Duintjer Tebbens, Mark A Pallansch, Stephen L Cochi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradicationRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 17, 2008
Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk managementRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 10, 2018
Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated SubpopulationsRadboud J Duintjer Tebbens, Mark A Pallansch, Stephen L Cochi, et al.
Pageof 7